The Molecular Tumor Board (MTB) is comprised of a group of experts that reviews and interprets molecular findings.  For information about how to attend the weekly Molecular Tumor Board meetings, please contact Michelle Turski, PhD.

A.Sweet-Cordero

Alejandro Sweet-Cordero, MD, Professor of Pediatrics (Hematology/Oncology), Director of the Molecular Oncology Initiative.

 

 

E.Collisson

Eric Collisson, MD, Associate Professor of Medicine (Hematology/Oncology), Molecular Tumor Board Discussant and Advisor.

 

 

M.Dhawan

Mallika Dhawan, MD, Assistant Professor of Medicine (Hematology/Oncology), Medical Director of Cancer Genetics Prevention Program and Hereditary Cancer Clinic.

 

 

J.Grabowski

Jennifer Grabowsky, PharmD, Oncology Pharmacist, Molecular Tumor Board Discussant and Advisor.

 

 

M.Moasser

Mark Moasser, MD, Professor of Medicine (Hematology/Oncology), Molecular Tumor Board Discussant and Advisor.

 

 

A.Olshen

Adam Olshen, PhD, Professor of Epidemiology and Biostatistics, Director of Computational Biology and Informatics Core, Molecular Oncology Initiative Technical Advisor.

 

 

M.Sabbadini

Marta Sabbadini PhDMS, Genetic Counselor, UCSF.

 

 

J.Schulte

Jessica Schulte, MD, PhD, Neuro-Oncologist, Molecular Tumor Board Discussant and Advisor.

 

 

E.Stieglitz

Elliot Stieglitz, MD, Assistant Professor of Pediatrics (Hematology/Oncology), Molecular Tumor Board Discussant and Advisor.

 

 

B.Winger

Beth Apsel Winger, MD, PhD, Assistant Professor of Pediatrics (Hematology/Oncology), Molecular Tumor Board Discussant and Advisor.

 

 

 


Support Staff:

Michelle Turski: Program Manager
Carlos Espinosa-Mendez: Computational scientist
Ana Quintanar Alfaro: Clinical Research Coordinator